Onco Wiki / Indication

HCV-associated Marginal Zone Lymphoma · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Trackstandard
Linked regimenNone
IDIND-SJOGREN-MALT-LYMPHOMA-PREVENTION-SURVEILLANCE
TypeIndication
Statusreviewed 2026-05-18 | pending_clinical_signoff
DiseasesDIS-HCV-MZL
SourcesSRC-NCCN-BCELL-2025

Notes

STUB — v0.3 chronic-condition prevention pilot (Sjögren's / MALT). Two-Co-Lead signoff queued. Disease anchor (DIS-HCV-MZL) is the closest in-KB MZL entity; a dedicated DIS-SALIVARY-MALT entity would be a future authoring task.

Used By

Indication

Red flag